Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria

The development of more effective vaccines against Mycobacterium tuberculosis has become a world priority. Previously, we have shown that a recombinant BCG expressing the LTAK63 adjuvant (rBCG-LTAK63) displayed higher protection than BCG against tuberculosis challenge in mice. In order to elucidate...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Carina Carvalho Dos Santos, Dunia Rodriguez, Alex Kanno Issamu, Luciana Cezar De Cerqueira Leite, Ivan Pereira Nascimento
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2020-03-01
Serija:	Human Vaccines & Immunotherapeutics
Teme:	tuberculosis vaccine recombinant bcg innate immunity long-term immunity
Online dostop:	http://dx.doi.org/10.1080/21645515.2019.1669414
Oznake:	Označite Brez oznak, prvi označite!